Journal: eLife
Article Title: The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells
doi: 10.7554/eLife.102681
Figure Lengend Snippet: ( A ) RT-qPCR detection of lnc-FANCI-2 in HPV16 + cervical cancer cell lines SiHa, CaSki, and W12 20861 (integrated HPV16) and 20863 (episomal HPV16), HPV18 + cervical cancer cell lines HeLa and C4II, and HPV - cell lines C33A (cervical cancer cells with mutations of p53 and pRb), HCT116 (colorectal cancer cells), BCBL-1 (body cavity B lymphoma cells), HEK293 (Ad5 E1/E2-immortalized human kidney cells), and HaCaT (spontaneously immortalized human epidermal cells) in triplicates. ( B ) HeLa cells express no lnc-FANCI-2 when compared with C33A cells by northern blot. ( C ) lnc-FANCI-2 is mainly cytoplasmic in CaSki but nuclear in SiHa and C33A cells. Cytoplasmic and nuclear fractionation efficiency was blotted for nuclear SRSF3 (serine- and arginine-rich splicing factor 3) and cytoplasmic GAPDH. Total fractionated cytoplasmic and nuclear RNAs were quantified for lnc-FANCI-2 by RT-qPCR in triplicates, with GAPDH RNA serving as an internal control for RNA fractionation efficiency. ( D ) Subcellular lnc-FANCI-2 (red) localization in CaSki, SiHa, and C33A cells determined by RNAscope RNA in situ hybridization (RNA-ISH) analysis. Nuclei were stained with DAPI (blue). Scale bars: 25 μm in the top and 10 μm in the zoom. Figure 2—source data 1. Northern blot and western blot data for . Figure 2—source data 2. Northern blot and western blot data for .
Article Snippet: Cell line ( Homo sapiens ) , C4II (HPV18 + ) , ATCC , CRL-1595 , Cervical cancer cell line.
Techniques: Quantitative RT-PCR, Northern Blot, Fractionation, Control, RNAscope, RNA In Situ Hybridization, Staining, Western Blot